ClinicalTrials.Veeva

Menu

Plasma Proteomics in Patients With Postoperative Delirium

X

Xuzhou Central Hospital (Xuzhou Fourth People's Hospital)

Status

Not yet enrolling

Conditions

Postoperative Delirium

Study type

Observational

Funder types

Other

Identifiers

NCT05772026
XuzhouCH2023

Details and patient eligibility

About

Patients undergoing cardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. . Plasma was isolated from peripheral blood for subsequent proteomic analysis.

Full description

Patients undergoing noncardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. Plasma was isolated from peripheral blood for subsequent proteomic analysis. To study the characteristics of proteins on a large scale, including protein expression levels, post-translational modifications, protein-protein interactions, etc., so as to obtain a comprehensive understanding of disease occurrence, cell metabolism and other processes at the protein level. Assessment of imbalanced protein expression in peripheral blood using protein profiling may allow us to better understand the pathological changes occurring at the molecular level of POD. Early detection of patients at high risk of POD can optimize perioperative management and promote rapid postoperative recovery.

Enrollment

200 estimated patients

Sex

All

Ages

65 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥65 years old, regardless of gender.
  • The patient had clear consciousness and no cognitive impairment, and could cooperate with the investigation and follow-up.
  • The ASA classification is I-Ⅲ.

Exclusion criteria

  • severe neurological or psychiatric disorders.
  • drug and alcohol abuse.
  • Patients with cognitive impairment caused by various reasons such as neuropsychiatric symptoms.
  • Exclusion criteria included incomplete medical records and failure to complete the postoperative follow-up.

Trial design

200 participants in 2 patient groups

POD group
Description:
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
non-POD group
Description:
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

Trial contacts and locations

0

Loading...

Central trial contact

Liwei Wang, Doctor; Yangzi Zhu, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems